Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Treatment Safety and Tolerability in Psychiatric Inpatient Care Delivered at Depatment of Psychiatry, Medical University of Gdańsk, Poland

NCT05565352 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.

NCT NCT05565352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05565352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Treatment Safety and Tolerability in Psychiatric Inpatient Care Delivered at Depatment of Psychiatry, Medical University of Gdańsk, Poland
Lead sponsor
Medical University of Gdansk
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2022
Completion date
December 31, 2029
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, dissociative disorder, major depressive disorder, obsessive-compulsive disorder, post traumatic stress disorder, somatoform disorders